T1	Pharmacological_substance 56 69	phenobarbital
N1000 	Reference T1 MeSH:D010634	phenobarbital
T2	Disorder 70 86	hypersensitivity
N1 	Reference T2 UMLS:C0020517	hypersensitivity
T3	Pharmacological_substance 107 120	phenobarbital
N1001 	Reference T3 MeSH:D010634	phenobarbital
T4	Disorder 121 137	hypersensitivity
N2 	Reference T4 UMLS:C0020517	hypersensitivity
T5	Disorder 181 186	fever
N3 	Reference T5 UMLS:C0015967	fever
T6	Disorder 232 240	alopecia
N4 	Reference T6 UMLS:C0002170	alopecia
T7	Disorder 242 249	icterus
N5 	Reference T7 UMLS:C0022346	icterus
T8	Disorder 251 277	protein-losing enteropathy
N6 	Reference T8 UMLS:C0033680	protein-losing enteropathy
T9	Disorder 279 287	myositis
N7 	Reference T9 UMLS:C0027121	myositis
T10	Disorder 293 302	nephritis
N8 	Reference T10 UMLS:C0027697	nephritis
T11	Disorder 350 362	eosinophilia
N9 	Reference T11 UMLS:C1636667	eosinophilia
N10 	Reference T11 UMLS:C0014457	eosinophilia
T14	Pharmacological_substance 641 654	phenobarbital
N1002 	Reference T14 MeSH:D010634	phenobarbital
T15	Disorder 739 755	hypersensitivity
N11 	Reference T15 UMLS:C0020517	hypersensitivity
T16	Pharmacological_substance 778 791	phenobarbital
N1003 	Reference T16 MeSH:D010634	phenobarbital
T18	Disorder 190 230	pruritic desquamating erythrodermic rash
T21	Subject 91 96	child
T24	Subject 45 50	child
T25	Disorder 9 39	Graft versus host-like illness
T26	Disorder 364 382	elevated serum IgE
T27	Disorder 388 425	elevated T suppressor/cytotoxic cells
T12	Disorder 514 540	cell-mediated pathogenesis
